Ligand Pharmaceuticals (LGND) Total Debt (2011 - 2026)

Ligand Pharmaceuticals has disclosed Total Debt across 13 years of filings, most recently posting $446.9 million for Q1 2026.

• Total Debt for Q1 2026 came in at $446.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $446.9 million (changed N/A YoY), and the FY2025 annual result was $446.2 million, changed N/A from the prior year.
• Total Debt came in at $446.9 million for Q1 2026 at Ligand Pharmaceuticals, roughly flat from $446.2 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $446.9 million in Q1 2026 to a low of $76.6 million in Q3 2022.
• The 4-year median for Total Debt is $115.0 million (2022), against an average of $240.5 million.